Arcutis Biotherapeutics Inc (ARQT) Insider Trading
- $26,579,888.32
- $23,313,583.80
- March 4, 2024
- Todd Franklin Watanabe
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 4, 2024 | Insider | 3,760 | $11.12 | Sell | $41,811.20 | |
Jan. 2, 2024 | Insider | 1,325 | $3.54 | Sell | $4,690.50 | |
Nov. 21, 2023 | Insider | 1,850 | $1.98 | Sell | $3,663.00 | |
Oct. 24, 2023 | Major Shareholder | 80,000 | $2.50 | Buy | $200,000.00 | |
Aug. 21, 2023 | Insider | 1,605 | $7.04 | Sell | $11,299.20 | |
May 31, 2023 | Insider | 1,830 | $7.80 | Sell | $14,274.00 | |
April 17, 2023 | Director | 8,500 | $13.97 | Sell | $118,745.00 | |
April 6, 2023 | Director | 8,500 | $12.01 | Sell | $102,085.00 | |
March 6, 2023 | SVP | 831 | $15.26 | Sell | $12,681.06 | |
March 6, 2023 | Insider | 2,435 | $15.26 | Sell | $37,158.10 | |
March 6, 2023 | CFO | 291 | $15.26 | Sell | $4,440.66 | |
March 2, 2023 | Insider | 5,472 | $15.83 | Sell | $86,621.76 | |
March 2, 2023 | SVP | 1,432 | $15.83 | Sell | $22,668.56 | |
March 2, 2023 | CFO | 1,434 | $15.83 | Sell | $22,700.22 | |
Feb. 28, 2023 | CFO | 416 | $16.17 | Sell | $6,726.72 | |
Feb. 28, 2023 | SVP | 936 | $16.17 | Sell | $15,135.12 | |
Feb. 28, 2023 | Insider | 2,343 | $16.17 | Sell | $37,886.31 | |
Feb. 15, 2023 | Director | 8,500 | $16.98 | Sell | $144,330.00 | |
Feb. 13, 2023 | Insider | 483 | $17.00 | Sell | $8,211.00 | |
Jan. 17, 2023 | Director | 8,500 | $13.72 | Sell | $116,620.00 | |
Jan. 3, 2023 | Insider | 1,475 | $15.01 | Sell | $22,139.75 | |
Dec. 7, 2022 | Insider | 1,000 | $17.06 | Sell | $17,060.00 | |
Nov. 21, 2022 | Insider | 1,720 | $18.19 | Sell | $31,286.80 | |
Nov. 7, 2022 | Insider | 1,000 | $18.00 | Sell | $18,000.00 | |
Oct. 7, 2022 | CEO | 1,000 | $19.51 | Sell | $19,510.00 | |
Oct. 4, 2022 | Director | 6,000 | $20.29 | Sell | $121,740.00 | |
Sept. 7, 2022 | CEO | 1,000 | $21.51 | Sell | $21,510.00 | |
Aug. 15, 2022 | Director | 6,000 | $24.80 | Sell | $148,800.00 | |
July 18, 2022 | N/A | 6,000 | $24.40 | Sell | $146,400.00 | |
July 18, 2022 | Director | 6,000 | $24.40 | Sell | $146,400.00 | |
July 8, 2022 | President and CEO | 1,500 | $25.00 | Sell | $37,500.00 | |
July 8, 2022 | Chief Technical Officer | 2,197 | $25.41 | Sell | $55,825.77 | |
July 6, 2022 | CEO | 1,000 | $22.07 | Sell | $22,070.00 | |
June 24, 2022 | Major Shareholder | 341,971 | $21.31 | Sell | $7,287,402.01 | |
June 2, 2022 | SVP | 1,795 | $19.73 | Sell | $35,415.35 | |
June 1, 2022 | Director | 2,500 | $20.62 | Sell | $51,550.00 | |
May 5, 2022 | CEO | 1,000 | $21.76 | Sell | $21,760.00 | |
May 2, 2022 | Director | 2,500 | $20.44 | Sell | $51,100.00 | |
April 21, 2022 | Insider | 2,197 | $20.42 | Sell | $44,862.74 | |
April 8, 2022 | Major Shareholder | 200,000 | $20.71 | Sell | $4,142,000.00 | |
April 6, 2022 | Major Shareholder | 333,204 | $20.69 | Sell | $6,893,990.76 | |
April 5, 2022 | CEO | 1,000 | $21.43 | Sell | $21,430.00 | |
April 1, 2022 | Director | 7,500 | $20.02 | Sell | $150,150.00 | |
March 9, 2022 | CEO | 300 | $17.00 | Sell | $5,100.00 | |
March 7, 2022 | CFO | 10 | $16.44 | Sell | $164.40 | |
March 7, 2022 | Insider | 30 | $16.44 | Sell | $493.20 | |
March 7, 2022 | CEO | 770 | $17.05 | Sell | $13,128.50 | |
March 4, 2022 | SVP | 993 | $16.86 | Sell | $16,741.98 | |
March 4, 2022 | Insider | 981 | $16.86 | Sell | $16,539.66 | |
March 4, 2022 | CFO | 293 | $16.86 | Sell | $4,939.98 |
Insiders are both buying and selling Arcutis Biotherapeutics Inc stock.
The insider traders at Arcutis Biotherapeutics Inc are: Todd Franklin Watanabe, Howard G Welgus, Bhaskar Chaudhuri, Scott L Burrows, Masaru Matsuda, Patrick Burnett, John W. Smither, Patricia A Turney, Orbimed Advisors Llc, Life Sciences Viii L Frazier, Jonathan Silverstein, Howard G. Welgus, David W. Osborne, David W Osborne, Watanabe Todd Franklin, Welgus Howard G., and OSBORNE DAVID W
The most active insider trader at Arcutis Biotherapeutics Inc is Todd Franklin Watanabe with 28 trades.
Orbimed Advisors Llc has sold the most Arcutis Biotherapeutics Inc stock with a total value of $25,610,794.78.
Jonathan Silverstein has bought the most Arcutis Biotherapeutics Inc stock with a total value of $28,659,776.64.
The most recent insider trade for Arcutis Biotherapeutics Inc was on March 4, 2024.
The single biggest insider buy for Arcutis Biotherapeutics Inc was from Jonathan Silverstein with a total value of $14,329,888.32 on Feb. 3, 2020.
The single biggest insider sell for Arcutis Biotherapeutics Inc was from Orbimed Advisors Llc with a total value of $7,287,402.01 on June 24, 2022.